SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SERINO, Maria Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.470
AS - Asia 3.354
EU - Europa 2.694
SA - Sud America 606
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 13.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.319
SG - Singapore 1.391
CN - Cina 974
IT - Italia 870
BR - Brasile 505
DE - Germania 438
UA - Ucraina 359
HK - Hong Kong 300
TR - Turchia 273
PL - Polonia 212
GB - Regno Unito 209
VN - Vietnam 187
FI - Finlandia 140
SE - Svezia 113
RU - Federazione Russa 85
CA - Canada 75
MX - Messico 64
FR - Francia 49
SM - San Marino 49
AR - Argentina 46
ID - Indonesia 46
NL - Olanda 41
IN - India 34
ZA - Sudafrica 34
JP - Giappone 31
ES - Italia 29
BE - Belgio 25
EC - Ecuador 24
CZ - Repubblica Ceca 22
BD - Bangladesh 18
LT - Lituania 16
IQ - Iraq 14
PK - Pakistan 12
AT - Austria 11
LK - Sri Lanka 11
EG - Egitto 8
IR - Iran 8
KE - Kenya 8
VE - Venezuela 8
CO - Colombia 7
PY - Paraguay 7
AU - Australia 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
IE - Irlanda 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
IL - Israele 4
NO - Norvegia 4
SA - Arabia Saudita 4
TH - Thailandia 4
AL - Albania 3
CL - Cile 3
JM - Giamaica 3
KR - Corea 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
UY - Uruguay 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.207
Salva come PNG Salva come JPEG
Città #
Singapore 718
Woodbridge 658
Ashburn 613
Fairfield 536
Chandler 484
Jacksonville 407
Beijing 359
Santa Clara 336
Hong Kong 299
Houston 299
Ann Arbor 261
Seattle 236
Wilmington 224
Warsaw 206
Cambridge 157
Izmir 150
Ferrara 129
Munich 128
Nanjing 112
New York 112
Los Angeles 110
Milan 101
Dallas 100
Princeton 86
Boardman 71
Shanghai 58
Ho Chi Minh City 55
Mexico City 46
San Diego 46
São Paulo 41
Turku 41
Bremen 38
Hanoi 35
London 35
Shenyang 34
Jakarta 33
Buffalo 32
Dearborn 32
Chicago 30
Hebei 30
Tokyo 30
Rome 29
Montreal 28
Nanchang 26
Orem 25
The Dalles 24
Brussels 23
Changsha 23
Toronto 23
Brooklyn 22
Helsinki 22
Johannesburg 22
Phoenix 22
Denver 20
Jiaxing 20
Redwood City 20
Rio de Janeiro 20
Boston 19
Düsseldorf 19
Tianjin 18
Stockholm 17
Nuremberg 16
Amsterdam 15
Curitiba 15
Hefei 15
Jinan 15
Mountain View 15
Naples 15
Bologna 14
Moscow 14
Brno 13
Falls Church 13
Chennai 12
Dong Ket 12
Frankfurt am Main 12
Manchester 12
Council Bluffs 11
Da Nang 11
Des Moines 11
Domagnano 11
Guangzhou 11
Meda 11
Atlanta 10
Brasília 10
Colombo 10
Haiphong 10
Kunming 10
Poplar 10
San Francisco 10
Washington 10
Auburn Hills 9
Augusta 9
Charlotte 9
Guayaquil 9
Jackson 9
Napoli 9
São Bernardo do Campo 9
Belo Horizonte 8
Orange 8
Ottawa 8
Totale 8.391
Salva come PNG Salva come JPEG
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 552
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 259
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 251
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 243
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 226
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 226
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 207
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 206
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 206
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 204
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 204
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 204
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 199
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 195
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 195
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 194
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 186
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 185
A photometric assay for factor-XIII in chronic hepatopathies. 183
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 182
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 182
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 176
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 173
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 172
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 170
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 163
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 160
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 157
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 154
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 153
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 153
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 151
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 148
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 146
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 146
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 146
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 145
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 143
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 140
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 139
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 138
Una "rete" per proteggere il cuore. (FAR 2013) 137
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 136
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 136
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 134
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 134
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 133
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 133
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 133
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 132
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 130
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 129
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 128
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 126
Malattie emorragiche vascolari. 126
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 123
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 122
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 122
null 118
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 117
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 116
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 116
Thrombotic risk in thalassemic patients 111
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 109
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 109
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 105
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 103
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 102
null 102
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 100
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 99
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 99
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 97
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 95
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 94
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 92
null 91
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 91
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 87
null 85
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 81
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 80
null 80
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 80
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 80
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 75
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 72
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 72
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 69
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 68
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 63
null 61
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 55
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 53
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 51
GRB 130427A: a Nearby Ordinary Monster 51
null 49
Totale 13.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 505
Totale 59.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021768 0 0 0 0 0 139 51 140 46 181 151 60
2021/2022837 30 77 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/20252.456 72 45 175 91 312 188 97 122 467 256 353 278
2025/20263.380 633 262 536 882 945 122 0 0 0 0 0 0
Totale 13.354